Inovio Pharmaceuticals Stock Target Price and Analyst Consensus

INO
 Stock
  

USD 1.97  0.07  3.43%   

The current analyst and expert consensus on Inovio Pharmaceuticals is Hold with 5 hold recommendations. The current projected Inovio Pharmaceuticals target price consensus is 13.63 with 8 analyst opinions. One of the most common ways Inovio Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Inovio Pharmaceuticals vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Inovio Pharmaceuticals. We strongly encourage you to use your own analysis of Inovio Pharmaceuticals to validate this buy or sell advice. Inovio Pharmaceuticals recommendation module provides expert sentiment on the projected Inovio Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 9.956. Please see Macroaxis Advice on Inovio Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Gross Profit is expected to rise to about 1.8 M this year, although the value of Profit Margin will most likely fall to (69.86) . Inovio Pharmaceuticals Shareholders Equity is quite stable at the moment as compared to the past year. The company's current value of Shareholders Equity is estimated at 431.22 Million. Goodwill and Intangible Assets is expected to rise to about 13.5 M this year, although the value of Receivables will most likely fall to about 5.1 M.

Inovio Pharmaceuticals Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inovio target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts performance other than comparing it to the past results via a very sophisticated attribution analysis. Inovio target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
Number of Opinions8
Lowered Outlook0
Raized Outlook0
Hold
Most Inovio analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Inovio stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Inovio Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Inovio Pharmaceuticals Target Price Projection

Inovio Pharmaceuticals' current and average target prices are 1.97 and 13.62, respectively. The current price of Inovio Pharmaceuticals is the price at which Inovio Pharmaceuticals is currently trading. On the other hand, Inovio Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Inovio Pharmaceuticals Market Quote on 1st of December 2022

Low Price1.9Odds
High Price2.0Odds

1.97

Target Price

Analyst Consensus On Inovio Pharmaceuticals Target Price

Low Estimate6.0Odds
High Estimate35.0Odds
Number of Analysts8
Standard Deviation9.956

13.625

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Inovio Pharmaceuticals and the information provided on this page.

Inovio Pharmaceuticals Analyst Ratings

Inovio Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Inovio Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Inovio Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Inovio Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Inovio Pharmaceuticals Target Price Projections

Inovio Pharmaceuticals's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Inovio Pharmaceuticals and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Inovio depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Inovio Pharmaceuticals including analysis of its current option contracts.
Inovio Pharmaceuticals' latest option contracts expiring on 2022-12-02 are carrying combined implied volatility of 118.83 with a put-to-call open interest ratio of 0.52 over 20 outstanding agreements suggesting investors are buying more calls than puts on contracts expiring on 2022-12-02. The current put volume is at 76, with calls trading at the volume of 149. This yields a 0.51 put-to-call volume ratio. The Inovio Pharmaceuticals option chain provides detailed quote and price information for the current Inovio Pharmaceuticals option contracts. It shows all of Inovio Pharmaceuticals' listed puts, calls, expiration dates, strike prices, and other pricing information.
Inovio Pharmaceuticals' stock options are financial instruments that give investors the right to buy or sell shares of Inovio Pharmaceuticals common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Inovio stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Inovio Pharmaceuticals' stock price goes up or down, the stock options follow.
Please see Macroaxis Advice on Inovio Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Inovio Current Options Market Mood

Inovio Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Inovio Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Most options investors, including buyers and sellers of Inovio Pharmaceuticals' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Inovio Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Inovio Pharmaceuticals' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.

Additional Inovio Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Inovio Pharmaceuticals is a key component of Inovio Pharmaceuticals valuation and have some predictive power on the future returns of a Inovio Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inovio Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inovio Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.102.057.30
Details
Intrinsic
Valuation
LowReal ValueHigh
0.244.8510.10
Details
Naive
Forecast
LowNext ValueHigh
0.0354451.777.02
Details
Earnings
Estimates (6)
LowProjected EPSHigh
-1.32-1.26-1.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharmaceuticals. Your research has to be compared to or analyzed against Inovio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inovio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inovio Pharmaceuticals.

Additional Inovio Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Inovio Pharmaceuticals is a key component of Inovio Pharmaceuticals valuation and have some predictive power on the future returns of a Inovio Pharmaceuticals.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Inovio Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Inovio Pharmaceuticals in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.102.057.30
Details
Intrinsic
Valuation
LowReal ValueHigh
0.244.8510.10
Details
Naive
Forecast
LowNext ValueHigh
0.0354451.777.02
Details
Earnings
Estimates (6)
LowProjected EPSHigh
-1.32-1.26-1.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Inovio Pharmaceuticals. Your research has to be compared to or analyzed against Inovio Pharmaceuticals' peers to derive any actionable benefits. When done correctly, Inovio Pharmaceuticals' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Inovio Pharmaceuticals.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Please see Macroaxis Advice on Inovio Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Inovio Pharmaceuticals price analysis, check to measure Inovio Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inovio Pharmaceuticals is operating at the current time. Most of Inovio Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Inovio Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Inovio Pharmaceuticals' price. Additionally, you may evaluate how the addition of Inovio Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
The data published in Inovio Pharmaceuticals' official financial statements usually reflect Inovio Pharmaceuticals' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inovio Pharmaceuticals. For example, before you start analyzing numbers published by Inovio accountants, it's critical to develop an understanding of what Inovio Pharmaceuticals' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Inovio Pharmaceuticals' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inovio Pharmaceuticals' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inovio Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inovio Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of Inovio Pharmaceuticals' management to manipulate its earnings.